Back to BlackRock, Inc. BlackRock, Inc.

CTSOCTSO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CYTOSORBENTS CORP

BlackRock, Inc. holds 627,211 shares of CTSO (CYTOSORBENTS CORP), worth $234,577 as of 2026-Q2. The position was decreased (-19.9% shares).

Current Value

$234,577

Current Shares

627,211

Total Value Change

-$336,271

Total Shares Change

-94

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
627,211
-19.9%
$234,5770.0%$0.37
0
2026-Q1
Increased
782,992
+1.6%
$443,4080.0%$0.80
17
2025-Q4
Increased
770,551
+0.8%
$492,5360.0%$0.64
16
2025-Q3
Increased
764,809
+2.6%
$714,4080.0%$0.93
17
2025-Q2
Increased
745,613
+18.9%
$954,3850.0%$1.23
20
2025-Q1
Unchanged
627,305
0.0%
$627,3050.0%$1.00
0
2024-Q4
New
627,305
-
$570,8480.0%$0.90
37

Other major holders of CTSO: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used